Back

Impact of artificial intelligence–enabled ECG implementation on diagnostic and longitudinal surveillance guideline adherence in hypertrophic cardiomyopathy

28 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy: artificial intelligence and risk prediction Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jorge Silva Enciso

University of California San Diego, San Diego (United States of America)

7 More presentations in this session

Presentation thumbnail
Distinct comorbidity and functional profiles in obstructive versus non-obstructive hypertrophic cardiomyopathy in the prospective TORCH registry
Doctor C. Reich (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Artificial intelligence–driven temporal clinical and ECG modeling for personalized sudden cardiac death risk prediction in hypertrophic cardiomyopathy
Doctor L. Ordine (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Evaluation of the localization of coronary microvascular dysfunction in obstructive hypertrophic cardiomyopathy and the therapeutic effects of alcohol septal ablation
Doctor T. Terauchi (Tsukuba, JP)
Abstract Slides Video
Presentation thumbnail
Long-term prognostic value of left ventricular outflow tract gradient in hypertrophic cardiomyopathy
Mr E. Klaassen Barba (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Enhancing clinical care in obstructive hypertrophic cardiomyopathy: the use of artificial intelligence for echocardiographic follow-up during treatment with mavacamten.
Ms A. Van Hoogdalem (NL)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy: artificial intelligence and risk prediction

The Event

Event poster

ESC Congress 2026

28 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Session
Late-Breaking Clinical Trials: artificial intelligence in cardiology
30 August 2025
thumbnail
Congress Presentation
Deep learning–based ECG detection and phenotype classification of hypertrophic cardiomyopathy
30 August 2026
thumbnail
Congress Presentation
Clinical–core lab discrepancies in echocardiography and their impact on implantable cardioverter-defibrillator eligibility in hypertrophic cardiomyopathy
29 August 2026
thumbnail
Congress Presentation
Continuous ambulatory ECG monitoring of up to 14 days increases detection of high-risk ventricular tachyarrhythmias compared with the first 48 hours in hypertrophic cardiomyopathy
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources